
Real-world data show that a shot that protects babies against RSV is 90% effective in keeping them out of the hospital. Those numbers outstrip what had been expected of Beyfortus (nirsevimab), which in clinical trials had prevented the need for medical care for RSV infection by 79% and hospitalization by 81%, researchers from the U.S.… read on > read on >